United States · FDA National Drug Code directory
Docetaxel
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57884-3043_05e0099c-4a6e-4ca4-e063-6394a90ae073
- Product NDC
- 57884-3043
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- Docetaxel
- Labeler
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170809
- Source listing expiry
- 20261231
Source-listed ingredients
- DOCETAXEL — 160 mg/8mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (57884-3043-1) / 8 mL in 1 VIAL, GLASS · 57884-3043-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →